These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6368232)

  • 41. [Determination of the optimal dose of captopril in the treatment of severe cardiac failure by hourly hemodynamic monitoring].
    Allal J; Pornin M; Rossi F; Poupet JY; Bordage JP; Barraine R
    Arch Mal Coeur Vaiss; 1984 Apr; 77(4):458-67. PubMed ID: 6426432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aldosterone and prolactin responsiveness after prolonged treatment of congestive heart failure with captopril.
    Jungmann E; Störger H; Althoff PH; Hadler D; Fassbinder W; Bussmann WD; Kaltenbach M; Schöffling K
    Eur J Clin Pharmacol; 1985; 28(1):1-4. PubMed ID: 3886398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Hemodynamic effects of the acute administration of captopril in refractory chronic congestive heart failure. Study of 13 patients and review of the literature].
    Dall'Aglio V; Rellini G; Charmet P; Cassin M; Variola A; Menin A; Manfroni A; Meneguzzo N; Bazzi A
    G Ital Cardiol; 1983 Sep; 13(9):153-9. PubMed ID: 6363191
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic and endocrine changes associated with captopril in diuretic-resistant hypertensive patients.
    Fujita T; Ando K; Noda H; Sato Y; Yamashita N; Yamashita K
    Am J Med; 1982 Sep; 73(3):341-7. PubMed ID: 6751080
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Angiotensin II is more potent than potassium in regulating aldosterone in cardiac failure: evidence during captopril therapy.
    Nicholls MG; Espiner EA; Ikram H; Maslowski AH; Lun S; Scandrett MS
    J Clin Endocrinol Metab; 1981 Jun; 52(6):1253-6. PubMed ID: 7014601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Management of congestive heart failure (2). Diuretic administration and vasodilator therapy of cardiac asthma and pulmonary edema (cardiac load reduction) with special reference to SQ 14225 (captopril)].
    Takatsu T; Tsutsumi J; Kubo S; Kino M; Nishioka A; Suwa M; Morita H; Hirota Y; Kitaura Y; Kawamura K
    Nihon Rinsho; 1980 Feb; 38(2):408-31. PubMed ID: 6993729
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparative analysis of the hemodynamic actions of captopril and sodium nitroprusside in severe chronic congestive heart failure.
    Hermanovich J; Awan NA; Lui H; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1211-4. PubMed ID: 6753551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixed venous blood temperature response to exercise in heart failure patients treated with short-term vasodilators.
    Shellock FG; Rubin SA
    Clin Physiol; 1985 Dec; 5(6):503-14. PubMed ID: 3912094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
    Schofield PM; Brooks NH; Lawrence GP; Testa HJ; Ward C
    Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.
    Chatterjee K; Parmley WW
    J Am Coll Cardiol; 1983 Jan; 1(1):133-53. PubMed ID: 6338075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Long-term treatment of chronic heart failure by an inhibitor of angiotensin converting enzyme].
    Komajda M; Eugène M; Evans J; Laurenceau JL; Hubermann JP; Thomas D; Drobinski G; Leprince JL; Ganty J; Wajman A; Guedj D; Grosgogeat Y
    Arch Mal Coeur Vaiss; 1983 Jan; 76(1):29-36. PubMed ID: 6303239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure.
    Awan NA; Needham KE; Lui H; Rutledge J; Amsterdam EA; Mason DT
    Am Heart J; 1982 Nov; 104(5 Pt 2):1224-8. PubMed ID: 6753553
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
    Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
    Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The relationship between diuretic dose, and the haemodynamic response to captopril in patients with cardiac failure.
    Flapan AD; Davies E; Williams BC; Shaw TR; Edwards CR
    Eur Heart J; 1992 Jul; 13(7):971-5. PubMed ID: 1644090
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term captopril therapy in congestive heart failure: serial hemodynamic and echocardiographic changes.
    Nakashima Y; Fouad FM; Tarazi RC
    Am Heart J; 1982 Oct; 104(4 Pt 1):827-33. PubMed ID: 6751057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Captopril in cardiac insufficiency. Immediate and long-term effects].
    Champoud O; Cribier A; Berland J; Moore N; Letac B
    Arch Mal Coeur Vaiss; 1984 Jul; 77(7):738-46. PubMed ID: 6433836
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasodilator therapy in chronic congestive heart failure.
    Schwartz AB; Chatterjee K
    Drugs; 1983 Aug; 26(2):148-73. PubMed ID: 6349967
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term captopril therapy in severe refractory congestive heart failure.
    Steingo L; Pocock WA; Flax H; Stein M; Barlow JB
    Br J Clin Pharmacol; 1982; 14 Suppl 2(Suppl 2):203S-208S. PubMed ID: 6753902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vasopressin, renin and norepinephrine levels before and after captopril administration in patients with congestive heart failure due to idiopathic dilated cardiomyopathy.
    Riegger GA; Kochsiek K
    Am J Cardiol; 1986 Aug; 58(3):300-3. PubMed ID: 3526857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mechanisms governing the postural response and baroreceptor abnormalities in chronic congestive heart failure: effects of acute and long-term converting-enzyme inhibition.
    Cody RJ; Franklin KW; Kluger J; Laragh JH
    Circulation; 1982 Jul; 66(1):135-42. PubMed ID: 6805978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.